Gary Taylor
Stock Analyst at TD Cowen
(0.49)
# 4,147
Out of 4,534 analysts
265
Total ratings
44.6%
Success rate
-3.6%
Average return
Main Sectors:
Stocks Rated by Gary Taylor
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AGL agilon health | Rated: Hold | $17 → $55 | $122.10 | -54.95% | 12 | May 11, 2026 | |
| ACHC Acadia Healthcare Company | Rated: Buy | $24 → $30 | $34.43 | -12.87% | 15 | Apr 28, 2026 | |
| DVA DaVita | Maintained: Hold | $139 → $157 | $234.10 | n/a | 26 | May 19, 2025 | |
| ELV Elevance Health | Maintained: Buy | $589 | $382.23 | n/a | 15 | Oct 16, 2024 | |
| UNH UnitedHealth Group | Maintained: Buy | $601 | $421.55 | n/a | 16 | Oct 11, 2024 | |
| SGRY Surgery Partners | Maintained: Buy | $36 | $16.03 | n/a | 8 | Aug 1, 2024 | |
| CI The Cigna Group | Maintained: Buy | $400 | $283.94 | n/a | 12 | Jul 29, 2024 | |
| HCA HCA Healthcare | Maintained: Buy | $371 → $360 | $370.42 | n/a | 21 | Apr 30, 2024 | |
| MOH Molina Healthcare | Maintained: Buy | $453 → $412 | $229.71 | n/a | 14 | Apr 30, 2024 | |
| UHS Universal Health Services | Maintained: Hold | $181 → $183 | $150.64 | n/a | 21 | Apr 30, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $427 → $396 | $398.20 | n/a | 19 | Apr 2, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $8 | $21.10 | n/a | 6 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $30 → $26 | $26.26 | n/a | 7 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $6 → $8.5 | $11.34 | n/a | 8 | Mar 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $84 → $91 | $65.84 | n/a | 12 | Feb 12, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3.5 | $10.61 | n/a | 2 | Nov 10, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $3 → $6 | $29.60 | n/a | 4 | Feb 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $3 → $1.75 | $4.50 | n/a | 5 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $6 → $7 | $11.08 | n/a | 5 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $21 | $21.75 | n/a | 1 | Jan 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $32 → $20 | $194.38 | n/a | 7 | Sep 21, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $55 → $20 | $25.71 | n/a | 5 | Feb 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | n/a | $3.12 | n/a | 9 | Dec 14, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $65 → $74 | $207.66 | n/a | 4 | Jan 30, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $114 → $132 | $281.48 | n/a | 4 | Jan 5, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $12 | $13.26 | n/a | 3 | Mar 6, 2014 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $7 | $0.000001 | n/a | 2 | Nov 2, 2010 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $51.00 | n/a | 1 | May 11, 2009 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $20.00 | n/a | 1 | Jan 27, 2009 |
agilon health
May 11, 2026
Rated: Hold
Price Target: $17 → $55
Current: $122.10
Upside: -54.95%
Acadia Healthcare Company
Apr 28, 2026
Rated: Buy
Price Target: $24 → $30
Current: $34.43
Upside: -12.87%
DaVita
May 19, 2025
Maintained: Hold
Price Target: $139 → $157
Current: $234.10
Upside: n/a
Elevance Health
Oct 16, 2024
Maintained: Buy
Price Target: $589
Current: $382.23
Upside: n/a
UnitedHealth Group
Oct 11, 2024
Maintained: Buy
Price Target: $601
Current: $421.55
Upside: n/a
Surgery Partners
Aug 1, 2024
Maintained: Buy
Price Target: $36
Current: $16.03
Upside: n/a
The Cigna Group
Jul 29, 2024
Maintained: Buy
Price Target: $400
Current: $283.94
Upside: n/a
HCA Healthcare
Apr 30, 2024
Maintained: Buy
Price Target: $371 → $360
Current: $370.42
Upside: n/a
Molina Healthcare
Apr 30, 2024
Maintained: Buy
Price Target: $453 → $412
Current: $229.71
Upside: n/a
Universal Health Services
Apr 30, 2024
Maintained: Hold
Price Target: $181 → $183
Current: $150.64
Upside: n/a
Apr 2, 2024
Maintained: Buy
Price Target: $427 → $396
Current: $398.20
Upside: n/a
Mar 1, 2024
Rated: Buy
Price Target: $8
Current: $21.10
Upside: n/a
Mar 1, 2024
Rated: Buy
Price Target: $30 → $26
Current: $26.26
Upside: n/a
Mar 1, 2024
Rated: Hold
Price Target: $6 → $8.5
Current: $11.34
Upside: n/a
Feb 12, 2024
Maintained: Buy
Price Target: $84 → $91
Current: $65.84
Upside: n/a
Nov 10, 2023
Maintained: Hold
Price Target: $3.5
Current: $10.61
Upside: n/a
Feb 13, 2023
Rated: Hold
Price Target: $3 → $6
Current: $29.60
Upside: n/a
Nov 14, 2022
Maintained: Hold
Price Target: $3 → $1.75
Current: $4.50
Upside: n/a
Nov 14, 2022
Maintained: Hold
Price Target: $6 → $7
Current: $11.08
Upside: n/a
Jan 11, 2021
Initiated Coverage: Buy
Price Target: $21
Current: $21.75
Upside: n/a
Sep 21, 2020
Downgraded: Sell
Price Target: $32 → $20
Current: $194.38
Upside: n/a
Feb 24, 2020
Maintained: Hold
Price Target: $55 → $20
Current: $25.71
Upside: n/a
Dec 14, 2017
Downgraded: Sell
Price Target: n/a
Current: $3.12
Upside: n/a
Jan 30, 2015
Maintained: Hold
Price Target: $65 → $74
Current: $207.66
Upside: n/a
Jan 5, 2015
Rated: Buy
Price Target: $114 → $132
Current: $281.48
Upside: n/a
Mar 6, 2014
Upgraded: Buy
Price Target: $12
Current: $13.26
Upside: n/a
Nov 2, 2010
Upgraded: Buy
Price Target: $7
Current: $0.000001
Upside: n/a
May 11, 2009
Upgraded: Buy
Price Target: n/a
Current: $51.00
Upside: n/a
Jan 27, 2009
Upgraded: Buy
Price Target: n/a
Current: $20.00
Upside: n/a